top of page
RsvHomebckground.jpg

RSV AND OLDER ADULTS

Being an older adult can put you at increased risk for severe infections from respiratory syncytial virus (RSV) (1)

While you may be doing everything you can to stay healthy, the immune system typically weakens with older age, and has a harder time fighting off infections, such as those from RSV.(1)


While RSV infections are typically mild, there is still a possibility it could pose a severe threat, especially in older adults.(1)

Part of that severe threat is that RSV infection can cause serious complications, such as exacerbation of congestive heart failure (CHF), asthma, and chronic obstructive pulmonary disease(COPD) in older adults.(2)

 

In older adults, RSV is a significant cause of pneumonia and other severe lower respiratory tract complications. RSV can cause severe infections that may lead to hospitalization in adults aged 60 and older and adults living with certain underlying conditions like CHF, asthma, and COPD (3)

RSV infection can have long-term effects on older adults​ (5)
 

RSV can diminish your independence, even after recovery. For older adults, certain daily tasks can become challenging after recovering from RSV infection,(6) such as:

Eating

Washing

Walking

Breathing

Talk to your doctor or pharmacist about vaccination and other ways to protect yourself and others from RSV.

Trademarks are owned by or licensed to the GSK group of companies.
Copyright ©
GlaxoSmithKline 2024. All rights reserved

REFERENCES:
1. Watson A;Therapeutic Advances in Respiratory Disease;2021;15;1-17 (v1.0)
2. Mayo Clinic;2021;1-5;RSV symptoms and causes (v1.0)
3. Curran D;Influenza Other Respir Viruses;2022;16;462-473 (v1.0)
4. Centers for Disease control and Prevention;2020;1-2;Healthcare providers should consider RSV (v1.0)
5. CDC;2022;1-2;RSV in Older Adults and Adults with Chronic Medical Conditions (v1.0)
6. CDC;2022;1-2;RSV Research and Surveillance (v1.0)

For any side effect(s), please contact Saudi Food and Drug Authority to report them on the toll-free number 19999.

45-SFDA-51

NP-SA-RSA-WCNT-240001, Date of preparation: May 2024

bottom of page